Meningitis Vaccine
PorA-specific differences found in antibody avidity after Men B vaccine
Published in Vaccine Weekly, November 3rd, 2004
According to recent research from the Netherlands, "A clinical phase II trial with an experimental hexavalent outer membrane vesicle (OMV) vaccine (HexaMen) containing six different porin A (PorAs) was carried out in toddlers (2 to 3 years) and schoolchildren (7 to 8 years) in the Netherlands. HexaMen exists of two OMVs each containing three different PorA types. The serum bactericidal activity (SBA) after vaccination against the six PorAs was significantly different and was higher in toddlers than in...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2004-11-03)
More Articles from Vaccine Weekly
- Cytomegalovirus Vaccine
Microneutralization assay using cytomegalovirus strains developed - MMR Vaccine
MMR vaccination not associated with developmental disorders - Malaria Vaccine
Incidence of severe malaria useful as endpoint for vaccine trials - Tuberculosis Vaccine
M. tuberculosis antigen structures confirm binding orientation - Virology Vaccine
Interfering vaccine converts virulent infection into immunizing one - AIDS/HIV Vaccine
HIV-1 immunogen vaccine plus antiretrovirals promotes virologic control - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
